期刊文献+

不同结构PEG-PCL共聚物纳米粒的制备及质量评价 被引量:1

Preparation of PEG-PCL copolymer nanoparticles with different structures and their quality evaluation
下载PDF
导出
摘要 为了比较聚乙二醇-聚己内酯(PEG-PCL)不同结构共聚物纳米粒的性质,采用开环聚合反应制备PCL-PEG-PCL和mPEG-b-PCL共聚物,通过FT-IR,1H-NMR和GPC进行结构确证,利用分子自组装技术分别形成了“蘑菇”结构和“刷”结构载姜黄素(CUR)纳米粒共聚物,对其性质进行了研究。结果表明:CUR以无定型态存在于纳米粒中,纳米粒形貌为球形核壳结构且分布均匀;受共聚物结构的影响,“蘑菇”结构纳米粒具有较小的平均粒径(105.71±3.20)nm、较高的载药量和包封率;PCL-PEG-PCL纳米粒表面形成了致密的PEG层,能有效防止蛋白质吸附,在体内具有良好的稳定性;“刷”结构纳米粒具有较低的临界胶束浓度(CMC)和良好的缓释性能,对HepG-2细胞增殖有较高的抑制作用。因此,研究载药纳米粒可为药物递送系统的选择以及不同结构纳米粒的临床应用提供参考。 In order to compare the properties of polyethylene glycol-polycaprolactone(PEG-PCL)with different structures,the PCL-PEG-PCL and mPEG-b-PCL copolymers are obtained by ring-opening polymerization method and characterized by FT-IR,1H-NMR and GPC.The curcumin-loaded nanoparticles of"mushroom"and"brush"are prepared via self-assembly method,and the properties of the two structural nanoparticles are studied.The results show that CUR is encapsulated into the nanoparticles with an amorphous state;the nanoparticles show a smooth surface with core-shell structures and good dispersibility.Influenced by the structure of the copolymer,the"mushroom"nanoparticles have a smaller average particle size of(105.71±3.20)nm,a higher drug loading and encapsulation efficiency.Since the surface of the PCL-PEG-PCL nanoparticles forms a dense PEG-layer,protein resistance studies show that the"mushroom"nanoparticles are good in vivo stability."Brush"nanoparticles have a lower CMC date and better sustained release properties,and have a higher inhibitory effect on HepG-2 cancer cell proliferation.The study of drug-loaded nanoparticles can provide reference for drug delivery system selection and clinical application of nanoparticles with different structures.
作者 李环 刘晓乐 王萌熙 杨亚星 尚青 史永利 LI Huan;LIU Xiaole;WANG Mengxi;YANG Yaxing;SHANG Qing;SHI Yongli(School of Chemical and Pharmaceutical Engineering,Hebei University of Science and Technology,Shijiazhuang,Hebei 050018,China;College of Pharmacy,Xinxiang Medical University,Xinxiang,Henan 453003,China)
出处 《河北科技大学学报》 CAS 2019年第3期215-225,共11页 Journal of Hebei University of Science and Technology
基金 河北省自然科学基金(H2018201807,H2016208058) 河北省高等学校科学技术研究项目(ZD2016009)
关键词 高分子合成化学 聚乙二醇-聚己内酯 两亲性共聚物 自组装 纳米粒 CUR polymer synthesis chemistry PEG-PCL amphiphilic copolymer self-assembly nanoparticle CUR
  • 相关文献

参考文献3

二级参考文献93

  • 1Bergmann T K,Green H,Brasch-Andersen C,et al. Retrospective study of the impact ofpharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer[J]. EuropeanJournal of Clinical Pharmacology , 2011,67(1) : 693-700.
  • 2Chopra A,Kim T S I O S,Martinez D,et al. Combined therapy of an established,highly aggressivebreast cancer in mice with paclitaxel and a unique DNA-based cell vaccine [J]. Int J Cancer, 2006,118(11): 2888-2898.
  • 3Stathopoulos G P, Katis C,Tsavdaridis D,et al. Front-line paclitaxel and topotecan chemotherapy inadvanced or metastatic non-small-cell lung cancer: a phase II trial [J]. Cancer Chemotherapy andPharmacology , 2006,58(11) : 555-560.
  • 4Iesalnieks I,Tange S,Scherer M N, et al. Paclitaxel promotes liver graft survival in rats and inhibitshepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with livercancer[J]. TVansf/a.^ _Proc,2002,34(6) : 2316-2317.
  • 5Spencer C M,Faulds D. Paclitaxel-a review of its pharmacodynamic and pharmacokinetic properties andtherapeutic potential in the treatment of cancer[J]. Drug,1994,48(5) : 794-847.
  • 6Liggins R T,Burt H M. Polyether-polyester diblock copolymers for the preparation of paclitaxel loadedpolymeric micelle formulations [J], Advanced Drug Delivery Reviews,2002,54(2) : 191-202.
  • 7Zhang X C,Jackson J K,Burt H M. Development of amphiphilic diblock copolymers as micellar carriers oftaxolOriginal Research Article [J]. Int J Pharm . 1996,132(1-2) : 195-206.
  • 8Dong Y C, Feng S S. Methoxy poly ( ethylene glycol )-poly ( lactide) (MPEG-PLA) nanoparticles forcontrolled delivery of anticancer drugs [J], Biomaterials^ 2004,25(14) : 2843-206.
  • 9Lee S C,Huh K M,Lee J,et at. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: Invitro and In vivo characterization Q]. Biomacromolecule', 2007,8(1) : 202-208.
  • 10Ruan G,Feng S S. Preparation and characterization of poly (lactic acid) -poly (ethylene glycol) -poly (lacticacid)(PLA-PEG-PLA)microspheres for controlled release of paclitaxel [J]. Biomaterials,2003,24(28):5037-5044.

共引文献17

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部